Back to Journals » Cancer Management and Research » Volume 13

LncRNA MALAT1 Promotes Survival of Epithelial Ovarian Cancer Cells by Downregulating miR-145-5p [Retraction]

Authors Wang K, Zhao Y, Wang YM

Received 17 September 2021

Accepted for publication 17 September 2021

Published 19 September 2021 Volume 2021:13 Pages 7251—7252

DOI https://doi.org/10.2147/CMAR.S339843



Wang K, Zhao Y, Wang YM. Cancer Management and Research. 2020;12:11359–11369

The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over the flow cytometry maps and western blot data presented in this article. There also appeared to be errors in the tumor size numbers (n = 108) reported in Table 1, where the subgroups of High and Low MALATI expression do not add up to 54 as reported.

The authors responded to our queries but were unable to provide the original raw data for their study and have therefore agreed to retract the article.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.